Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.

H. Nüßlein, Manuela Le Bars, C. Rauch et al.|PubMed|2016

Cited by 32